| Code | CSB-RA884484MB3HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is a research-grade biosimilar to PMC-309, designed to specifically target VSIR (V-Set Immunoregulatory Receptor), also known as VISTA, B7-H5, or C10orf54. VSIR functions as an immune checkpoint protein expressed on hematopoietic cells, particularly myeloid cells and T lymphocytes, where it delivers inhibitory signals that suppress T cell activation and proliferation. This receptor plays a critical role in maintaining immune homeostasis and preventing excessive inflammatory responses. Dysregulation of VSIR has been implicated in various pathological conditions, including cancer immune evasion, autoimmune diseases, and chronic inflammatory disorders, making it an important therapeutic target for immunomodulation research.
PMC-309 represents a reference antibody used extensively in preclinical studies investigating VSIR-mediated immune regulation and checkpoint blockade mechanisms. This biosimilar provides researchers with a reliable tool for exploring VSIR's role in tumor microenvironments, studying immune cell interactions, and evaluating potential immunotherapeutic strategies. The antibody supports investigations into cancer immunology, transplant tolerance, and inflammatory disease models, enabling detailed characterization of VSIR expression patterns and functional consequences across diverse experimental systems.
There are currently no reviews for this product.